Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer
2020/12/08 by Van-Nghia Nguyen, Nguyễn Văn Nghĩa, Yuxin Yan +2 · 643 citations
Chemistry · Engineering · Materials Science · #Atom (system on chip) #Chemistry #Combinatorial chemistry #Computer science #Design elements and principles #Luminescence and Fluorescent Materials #Materials science #Nanoplatforms for cancer theranostics #Nanotechnology #Organic chemistry #Photochemistry #Photodynamic therapy #Photosensitizer #Porphyrin and Phthalocyanine Chemistry
paper · doi:10.1021/acs.accounts.0c00606
published in Accounts of Chemical Research 54(1), 207-220 (American Chemical Society)
openalex publication_date 2020/12/08 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04
Abstract
Conspectus Photodynamic therapy (PDT) is a clinically approved therapeutic modality that has shown great potential for the treatment of cancers owing to its excellent spatiotemporal selectivity and inherently noninvasive nature. However, PDT has not reached its full potential, partly due to the lack of ideal photosensitizers. A common molecular design strategy for effective photosensitizers is to incorporate heavy atoms into photosensitizer structures, causing concerns about elevated dark toxicity, short triplet-state lifetimes, poor photostability, and the potentially high cost of heavy metals. To address these drawbacks, a significant advance has been devoted to developing advanced smart photosensitizers without the use of heavy atoms to better fit the clinical requirements of PDT. Over the past few years, heavy-atom-free nonporphyrinoid photosensitizers have emerged as an innovative alternative class of PSs due to their superior photophysical and photochemical properties and lower expense. Heavy-atom-free nonporphyrinoid photosensitizers have been widely explored for PDT purposes and have shown great potential for clinical oncologic applications. Although many review articles about heavy-atom-free photosensitizers based on porphyrinoid structure have been published, no specific review articles have yet focused on the heavy-atom-free nonporphyrinoid photosensitizers. In this account, the specific concept related to heavy-atom-free photosensitizers and the advantageous properties of heavy-atom-free photosensitizers for cancer theranostics will be briefly introduced. In addition, recent progress in the development of heavy-atom-free photosensitizers, ranging from molecular design approaches to recent innovative types of heavy-atom-free nonporphyrinoid photosensitizers, emphasizing our own research, will be presented. The main molecular design approaches to efficient heavy-atom-free PSs can be divided into six groups: (1) the approach based on traditional tetrapyrrole structures, (2) spin–orbit charge-transfer intersystem crossing (SOCT-ISC), (3) reducing the singlet–triplet energy gap (Δ E ST ), (4) the thionation of carbonyl groups of conventional fluorophores, (5) twisted π-conjugation system-induced intersystem crossing, and (6) radical-enhanced intersystem crossing. The innovative types of heavy-atom-free nonporphyrinoid photosensitizers and their applications in cancer diagnostics and therapeutics will be discussed in detail in the third section. Finally, the challenges that need to be addressed to develop optimal heavy-atom-free photosensitizers for oncologic photodynamic therapy and a perspective in this research field will be provided. We believe that this review will provide general guidance for the future design of innovative photosensitizers and spur preclinical and clinical studies for PDT-mediated cancer treatments.
Cited by
- STAT3 PathwayTargeting Type I Photosensitizer asan Immune Stimulator for Cancer Photoimmunotherapy
- Near-infrared boron–dipyrrin (BODIPY) nanomaterials: Molecular design and anti-tumor therapeutics
- Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
- Construction of BODIPY-based triangular metallacycles with tunable photosensitization efficiency
- Chalcogen-doped carbon nanohoops with efficient near-infrared emission and singlet oxygen generation
- Orthogonal configurative dye 2-anthryl asymmetric aza-BODIPY enhancing SOCT-ISC for phototherapy
- Extended π‐Conjugated Bridge Strategy for an Enhanced Stokes Shift and Multimodal Imaging‐Guided Type I/II Photodynamic Therapy Integrated With Photothermal Therapy
- Aggregation-Induced-Emission Luminogens Functionalized MXene Nanosheets for Stimuli-Responsive Hydrogel in Pyroptosis-Mediated Choroidal Melanoma Therapy
- Dual Redox Behavior of Mitochondria‐Targeting Antioxidant: Prooxidant Activity Through Light‐Induced Redox Active Triplet State
- G-quadruplex-driven molecular disassembly and type I-to-type II photophysical conversion of a heavy-atom-free photosensitizer for site-specific oxidative damage
- Soranjidiol as a photosensitizer: Mechanistic insights into its photochemistry and photoinduced tautomerization
- BODIPY: synthesis, modification, and applications in sensing and biomedicine
- New Cy5 photosensitizers for cancer phototherapy: a low singlet-triplet gap provides high quantum yield of singlet oxygen. [europepmc]
- Orthogonally aligned cyclic BODIPY arrays with long-lived triplet excited states as efficient heavy-atom-free photosensitizers. [europepmc]
- Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy. [europepmc]
- Golgi apparatus-targeted aggregation-induced emission luminogens for effective cancer photodynamic therapy. [europepmc]
- Singlet Oxygen Generation from Polyaminoglycerol by Spin-Flip-Based Electron Transfer. [europepmc]
- AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy. [europepmc]
- A host-guest strategy for converting the photodynamic agents from a singlet oxygen generator to a superoxide radical generator. [europepmc]
- Tumor Microenvironment: Lactic Acid Promotes Tumor Development. [europepmc]
- Chemiluminescence in Combination with Organic Photosensitizers: Beyond the Light Penetration Depth Limit of Photodynamic Therapy. [europepmc]
- Recent Progress in Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy. [europepmc]
- Site-selected thionated benzothioxanthene chromophores as heavy-atom-free small-molecule photosensitizers for photodynamic therapy. [europepmc]
- Pillararene-Based Supramolecular Polymers for Cancer Therapy. [europepmc]
- Heavy Atom-Free Triplet Photosensitizers: Molecular Structure Design, Photophysical Properties and Application in Photodynamic Therapy. [europepmc]
- Immuno-photodynamic Therapy (IPDT): Organic Photosensitizers and Their Application in Cancer Ablation. [europepmc]
- Recent Advances in Applications of Fluorescent Perylenediimide and Perylenemonoimide Dyes in Bioimaging, Photothermal and Photodynamic Therapy. [europepmc]
- Origin of intersystem crossing in highly distorted organic molecules: a case study with red light-absorbing N , N , O , O -boron-chelated Bodipys. [europepmc]
- Distance dependence of enhanced intersystem crossing in BODIPY-nitroxide dyads. [europepmc]
- BODIPY-Based Molecules for Biomedical Applications. [europepmc]
- Fine-tuning of stable organic free-radical photosensitizers for photodynamic immunotherapy. [europepmc]
- Lutetium Texaphyrin-Celecoxib Conjugate as a Potential Immuno-Photodynamic Therapy Agent. [europepmc]
- Photodynamic Therapy in the Treatment of Cancer-The Selection of Synthetic Photosensitizers. [europepmc]
- Lowering of the singlet-triplet energy gap via intramolecular exciton-exciton coupling. [europepmc]
- Exploring the Versatile Uses of Triplet States: Working Principles, Limitations, and Recent Progress in Phosphorescence, TADF, and TTA. [europepmc]
- Aggregation control of anionic pentamethine cyanine enabling excitation wavelength selective NIR-II fluorescence imaging-guided photodynamic therapy. [europepmc]
- Phototherapy in cancer treatment: strategies and challenges. [europepmc]
Related